Background/Aims-Regional differences
by ulcerative colitis. Novel monoclonal antibodies (MAbs) were used in this study to investigate regional heterogeneity in the colonic mucosa.
Methods-MAbs generated using a method of tolerisation against common antigens in the proximal colon and distal colon were used for inmunoperoxidase stainig, comparative histochemistry, immunoblotting, and slot-blot analysis. Results-The colon specific MAbs SF1 (IgG3) and 6G4 (IgM) stained goblet cell contents throughout the normal distal colon but staining was markedly reduced in the proximal colon (p<00001). In the distal colon of patients with ulcerative colitis, whether quiescent or actively inflamed, reactivity was reduced compared with controls (p<O05, p<0001 respectively). By contrast, an overall increase in staining was seen in the uninflamed proximal colon in ulcerative colitis compared with controls (p<002). Comparative staining with high iron dianine and biochemical analyses indicated that MAb 6G4 was reactive with mucin bearing sulphate or O-acetylated sialic acid groups, or both.
Conclusions-Regional differences in the staining characteristics of normal colonic mucin have been shown using novel monoclonal antibodies. The pattern of mucin expression throughout the colon in ulcerative colitis is altered even in the absence of histological changes. (Gut 1997; 40: 234-240) Keywords: colonic mucin, monoclonal antibodies, ulcerative colitis.
In ulcerative colitis the rectum is nearly always affected, while the proximal extent of colonic involvement is variable. At presentation, approximately 50% of patients will have distal disease (limited to the recto-sigmoid), 25% will have left sided colitis (extending no further than the splenic flexure), and the remainder will have subtotal or pancolitis.lA Proximal extension of disease previously limited to the distal colon may occur in up to 30% of patients after 20 years of follow Up.3 5 The factors responsible for this striking regional variation in disease susceptibility in the colon remain unknown and disease progression within individual patients cannot be predicted. 1/100 in 33% normal swine serum in TRIS buffered saline (TBS) was applied for 30 minutes after washing in TBS. Negative controls were provided by incubating with secondary antibody alone. Slides were developed in a solution of diaminobenzidine, 75 mg in 150 ml TBS, with 450 ,ul H202 added just before use. After counterstaining with haematoxylin, slides were dehydrated in alcohol, cleared in xylene, and mounted in DPX mountant (BDH Laboratory Supplies).
Specificity of immunoperoxidase staining
A variety of frozen sections were used to examine the specificity of observed staining. Normal extracolonic tissues included stomach (5), duodenum (6), terminal ileum (1), liver (3), pancreas (1), skin (4), kidney (1), and lung (1). Colonic controls included Crohn's disease (10), cancer (5), and Shigella colitis (1).
Comparison between immunoperoxidase staining in normal subjects and patients with ulcerative colitis Fourteen subjects with normal colonic histology undergoing routine colonoscopy were compared with ulcerative colitis patients. These comprised people with quiescent or actively inflamed proximal (12, 5) (Fig 2) . Semiquantitative staining scores are shown in Figure 3 . There was 84% concordance between the scores assigned by the two observers. Reduced staining was also seen in Crohn's colitis, especially in cases of active inflammation and in colonic cancers (Table III) . Comparison between MAb staining and histology in quiescent ulcerative colitis Table IV shows MAb staining scores and histology of non-inflamed mucosa from patients with ulcerative colitis. In the proximal colon, scores greater than the median expected in normal mucosa were found with both antibodies in five of 12 cases, of which three had no histological evidence of involvement by ulcerative colitis. By contrast, in the distal colon, scores were less than would be expected with both antibodies for normal mucosa in eight of 13 cases, all of which displayed some histological abnormality. Hence there was no consistent relation between histology and MAb staining.
Comparison between MAb 6G4 staining and high iron diamine/alcian blue staining After microwave heating of formalin fixed sections, MAb 6G4 gave staining of a similar pattern and quality to that obtained with frozen sections. Immunostaining with MAb 5F1 was unsuccessful. The semiquantitative scores assigned to MAb 6G4 and high iron diamine staining of parallel sections from patients with ulcerative colitis (7) and infectious colitis (1) in different states of inflammation corresponded exactly in 17 of 20 cases. Examples are illustrated in Figure 4 . By contrast, there was agreement in staining scores for MAb 6G4 and alcian blue in only six of 20 cases. However it is possible that the alcian blue stain was obscured in some cases by the dense high iron diamine precipitate present in the same section.
Biochemical characterisation of the antigens reactive with MAbs 5F1 and 6G4
On probing western blots of normal colonic mucosa MAb 6G4 yielded a broad band of at least 200 kDa, consistent with a mucus glycoprotein (Fig 5) . MAb 5F1 failed to react with both dithiothreitol reduced and non-reduced blots. 
Discussion
In this study two murine monoclonal antibodies (5F1 and 6G4) were generated that were highly specific for the colon and displayed clear regional differences in staining of normal colonic mucosa. Both reacted with goblet cell contents and free luminal mucin, suggesting that they recognised epitopes located on mucus glycoproteins, or on products co-secreted with mucin. Both displayed gradients of reactivity, not only within colonic crypts but also along the colonic axis in a distal direction. In A group of three murine MAbs with a similar staining profile has recently been described.'9
The antibodies reacted with 'large intestinal mucin antigen' (LIMA), were colon specific, and showed a clear proximal to distal gradient of staining that was reduced in cases of colon cancer. Systematic examination of cases of inflammatory bowel disease was not undertaken although reduced staining was noted in some instances. Full biochemical characterisation of the presumed mucin borne antigens was not described. While the identity of the epitope recognised by MAb 5F1 has not been elucidated here, for MAb 6G4 the data are consistent with binding to moieties that bear ester sulphate or O-acetylated sialic acid residues, or both. No firm conclusions can be drawn regarding the nature of the antigen recognised by MAb 5F1 because this antibody failed to react both with mucin slot blots and western blots. This lack of reactivity may have resulted from changes in epitope configuration on binding to the membranes used in these experiments. Nevertheless, the similarity between the staining profiles obtained with MAb 5F1 and MAb 6G4 may indicate that they recognise closely related antigens. The immunohistochemical data reported here are also consistent with binding of sulphated or 0-acetylated sialomucins, or both, by MAbs 5F1 and 6G4. Increased expression of sulphomucins and O-acetylated sialomucins in the normal distal colon compared with the proximal colon has been suggested by biochemical, metabolic, and histochemical studies.2-23 In ulcerative colitis, it seems that mucosal expression of these types of mucin is decreased, even in the absence of acute inflammation.2>23 Interestingly, increased incorporation of radiolabelled sulphate in colonic glycoproteins of the unaffected proximal colon has been reported in patients with ulcerative colitis,24 a finding that is supported by the immunohistochemical data in this study. Other workers have described monoclonal antibodies that are thought to recognise O-acetylated sialomucin (MMM-17'5 and PR.3A525) and sulphomucin (91 9H26). However, regional differences in staining of the normal colon and mucin expression in ulcerative colitis have not been explored using these antibodies.
Whether an abnormality of mucin is of primary importance in the aetiology of ulcerative colitis remains controversial. Specific depletion of a mucin subclass ('Fraction IV') has been found in ulcerative colitis by chromatographic techniques.'0 27 Although these data have been challenged28 it is of interest that a subclass defect has also been reported in unaffected identical twins of patients with ulcerative colitis.29 This finding supports the notion that a genetic susceptibility to ulcerative colitis may be expressed at the level of the colonic epithelial cell. The biochemical nature of Fraction IV has not been characterised, but a study using monoclonal antibodies suggested that this mucin subclass was expressed mainly in the distal colon. 30 In functional terms, a mucin abnormality in ulcerative colitis may render the colonic epithelium vulnerable to attack by microorganisms and their products. It is thought that both sulphation and O-acetylation reduce mucin degradation by bacterial enzymes."' 31 32 Thus abnormalities of sulphation or 0-acetylation in ulcerative colitis may result in a loss of mucus barrier function and exposure of the mucosa to luminal agents that promote or perpetuate inflammation. The typical disease distribution of ulcerative colitis might then be explained, either because of increasing concentrations of bacterial glycosidases in a distal direction, or because mucin abnormalities in ulcerative colitis may be region specific. In this study, relatively deficient expression of mucins reactive with MAbs 5F1 and 6G4 was shown in the distal colon of patients with ulcerative colitis even in the absence of inflammation.
However, immunoreactivity was also increased in several cases in the proximal colon in both quiescent and active disease. These findings do not therefore suggest a simple reduction in the expression of certain mucin species in ulcerative colitis. Instead they are consistent with abnormal epithelial metabolism or disturbed kinetics of mucin synthesis affecting the colon to a variable extent, irrespective of disease activity. It remains to be seen whether increased immunoreactivity with MAbs 5F1 and 6G4 in the proximal colon of patients with distal ulcerative colitis will prove to be a useful marker for identifying those people, perhaps a genetically distinct subgroup, who are at risk of disease extension. 
